Cargando…

High BRAF(V600E) mutation frequency in Chinese patients with papillary thyroid carcinoma increases diagnostic efficacy in cytologically indeterminate thyroid nodules

To estimate the BRAFV600E mutation frequency in Chinese patients with papillary thyroid carcinoma (PTC), and the diagnostic value of BRAFV600E mutation status in thyroid nodules with indeterminate TBSRTC categories. A total of 4875 consecutive samples for thyroid ultrasound-guided fine-needle aspira...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xing-Jia, Mao, Xiao-dong, Chen, Guo-fang, Wang, Qi-feng, Chu, Xiao-qiu, Hu, Xin, Ding, Wen-bo, Zeng, Zheng, Wang, Jian-hua, Xu, Shu-hang, Liu, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6641833/ https://www.ncbi.nlm.nih.gov/pubmed/31305422 http://dx.doi.org/10.1097/MD.0000000000016343

Ejemplares similares

Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
por: Rowe, Leslie R, et al.
Publicado: (2006)

BRAF mutation in cytologically indeterminate thyroid nodules: after reclassification of a variant thyroid carcinoma
por: Pongsapich, Warut, et al.
Publicado: (2019)

Diagnostic Efficacy of Ultrasound, Cytology, and BRAF(V600E) Mutation Analysis and Their Combined Use in Thyroid Nodule Screening for Papillary Thyroid Microcarcinoma
por: Du, Jing, et al.
Publicado: (2022)

Indeterminate Thyroid Nodules: From Cytology to Molecular Testing
por: Vignali, Paola, et al.
Publicado: (2023)

Q-Elastography in the Presurgical Diagnosis of Thyroid Nodules with Indeterminate Cytology
por: Cantisani, Vito, et al.
Publicado: (2012)

Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules
por: Goldner, Whitney S., et al.
Publicado: (2019)

Performance of multigene testing in cytologically indeterminate thyroid nodules and molecular risk stratification
por: Zhou, Yuanyuan, et al.
Publicado: (2023)

Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules
por: Dharampal, Navjit, et al.
Publicado: (2022)

Diagnostic performance of shear wave elastography in thyroid nodules with indeterminate cytology: A systematic review and meta-analysis
por: Qiu, Yuxuan, et al.
Publicado: (2023)

ODP465 BRAF V600 and NRAS Q61 mutations in thyroid fine-needle aspiration (FNA) with indeterminate cytology in Argentina
por: Repetto, Esteban M, et al.
Publicado: (2022)

Preoperative detection of TERT promoter and BRAF(V600E) mutations in papillary thyroid carcinoma in high-risk thyroid nodules
por: Giorgenon, Tatiana Marina Vieira, et al.
Publicado: (2019)

A Genomic Alternative to Identify Medullary Thyroid Cancer Preoperatively in Thyroid Nodules with Indeterminate Cytology
por: Kloos, Richard T., et al.
Publicado: (2016)

Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations
por: Whitmer, Dorota, et al.
Publicado: (2022)

Cytologically indeterminate thyroid nodules: increased diagnostic performance with combination of US TI-RADS and a new scoring system
por: He, Ya-Ping, et al.
Publicado: (2017)

BRAF(V600E) vs. TIRADS in predicting papillary thyroid cancers in Bethesda system I, III, and V nodules
por: Wu, Ya, et al.
Publicado: (2019)

Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate
por: Wu, Dandan, et al.
Publicado: (2020)

ThyroidPrint®: clinical utility for indeterminate thyroid cytology
por: Olmos, Roberto, et al.
Publicado: (2023)

Comparison of Afirma GEC and GSC to Nodules Without Molecular Testing in Cytologically Indeterminate Thyroid Nodules
por: Polavarapu, Preethi, et al.
Publicado: (2021)

Risk and Prognostic Factors for BRAF(V600E) Mutations in Papillary Thyroid Carcinoma
por: Wei, Xiaojing, et al.
Publicado: (2022)

Comparison of S-Detect and thyroid imaging reporting and data system classifications in the diagnosis of cytologically indeterminate thyroid nodules
por: Zhou, Ling, et al.
Publicado: (2023)

Frequency and Significance of Ras, Tert Promoter, and Braf Mutations in Cytologically Indeterminate Thyroid Nodules: A Monocentric Case Series at a Tertiary-Level Endocrinology Unit
por: Censi, Simona, et al.
Publicado: (2017)

Diagnostic performance of Midkine ratios in fine-needle aspirates for evaluation of Cytologically indeterminate thyroid nodules
por: Zhou, Le, et al.
Publicado: (2021)

False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma
por: Paek, Se Hyun, et al.
Publicado: (2017)

Association between the BRAF V600E mutation and ultrasound features of the thyroid in thyroid papillary carcinoma
por: Li, Qian, et al.
Publicado: (2017)

Diagnostic performance of ultrasound risk stratification systems on thyroid nodules cytologically classified as indeterminate: a systematic review and meta-analysis
por: Xing, Zhichao, et al.
Publicado: (2023)

BRAF V600E and lymph node metastases in papillary thyroid cancer
por: Chen, Pan, et al.
Publicado: (2020)

The Mcgill thyroid nodule score – does it help with indeterminate thyroid nodules?
por: Varshney, Rickul, et al.
Publicado: (2015)

Increased diagnostic sensitivity of palpation‐guided thyroid nodule fine‐needle aspiration cytology by BRAF V600E‐mutation analysis
por: Gimm, Oliver, et al.
Publicado: (2021)

Indeterminate Thyroid Nodules: When to Worry?
por: Tibbels, Amanda
Publicado: (2023)

Evaluation and Management of Indeterminate Thyroid Nodules: The Revolution of Risk Stratification Beyond Cytological Diagnosis
por: Valderrabano, Pablo, et al.
Publicado: (2017)

The value of routine measurement of serum calcitonin on insufficient, indeterminate, and suspicious thyroid nodule cytology
por: Sencar, Muhammed Erkam, et al.
Publicado: (2022)

An innovative synthetic support for immunocytochemical assessment of cytologically indeterminate (Bethesda III) thyroid nodules
por: Taccogna, Silvia, et al.
Publicado: (2022)

Differential diagnosis of diffuse sclerotic thyroid papillary carcinoma and Hashimoto's thyroiditis using fine‐needle aspiration cytology, BRAF(V600E), and ultrasound elastography
por: Wang, Xian, et al.
Publicado: (2022)

Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology
por: Sciacchitano, Salvatore, et al.
Publicado: (2017)

Clinical implication of the BRAF(V600E) mutation in papillary thyroid carcinoma
por: Kim, Yong-Seok, et al.
Publicado: (2013)

Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma
por: HE, GUOPING, et al.
Publicado: (2014)

Relationship between BRAF V600E and clinical features in papillary thyroid carcinoma
por: Yan, Changjiao, et al.
Publicado: (2019)

Diagnostic utility of BRAF(V600E )mutation testing in thyroid nodules in elderly patients
por: Guerra, Anna, et al.
Publicado: (2013)

Analytical Verification Performance of Afirma Genomic Sequencing Classifier in the Diagnosis of Cytologically Indeterminate Thyroid Nodules
por: Hao, Yangyang, et al.
Publicado: (2019)

OR27-2 Inter-reader Agreement of ATA Sonographic Risk In Thyroid Nodules With Indeterminate Cytology
por: Linares, Maria, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bd9b7jkjhmvcirsihe3nerni4m